Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GlucoMe’s digital diabetes management solution has demonstrated clinical benefit in pilot studies, including a reduction in HbA1c levels within 12 weeks and improved patient compliance. In Vietnam pilots with Merck KGaA, the system achieved high patient retention rates and significant improvements in glycemic control. The platform enables remote monitoring, frequent patient-provider interactions without increasing staff resources, and rapid scaling across healthcare systems. It is commercially launched or piloted in Vietnam, India, Central America, and other regions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GlucoMe.